Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts
Authors:
- Chiara FabbriCFChiara Fabbri
- Saskia P. HagenaarsSHSaskia P. Hagenaars
- Catherine JohnCJCatherine John
- Alexander T. WilliamsAWAlexander T. Williams
- Nick ShrineNSNick Shrine
- Louise MolesLMLouise Moles
- Ken B. HanscombeKHKen B. Hanscombe
- Alessandro SerrettiASAlessandro Serretti
- David J. ShepherdDSDavid J. Shepherd
- Robert S. FreeRFRobert S. Free
- Louise V. WainLWLouise V. Wain
- Martin D. TobinMTMartin D. Tobin
Preprint
Abstract
Treatment-resistant depression (TRD) is a major contributor to the disability caused by major depressive disorder (MDD). Using primary care electronic health records from UK Biobank and EXCEED studies, we defined MDD and TRD, providing an easily accessible approach to investigate their clinical and genetic characteristics. MDD defined from primary care records was compared with other measures of depression and validated using the MDD polygenic risk score (PRS). Using prescribing records, TRD was defined from at least two switches between antidepressant drugs, each prescribed for at least six weeks. Clinical-demographic characteristics, SNP-heritability and genetic overlap with psychiatric and non-psychiatric traits were compared in TRD and non-TRD MDD cases. In 230,096 and 8,926 UKB and EXCEED participants with primary care data, respectively, the prevalence of MDD was 8.7% and 14.2%, of which 13.2% and 13.5% was TRD (2,430 and 159 cases), respectively. In both cohorts, MDD defined from primary care records was strongly associated with MDD PRS, and in UKB it showed overlap of 72%-88% with other MDD definitions. In UKB, TRD and non-TRD heritability was comparable (h 2 SNP = 0.25 [SE=0.04] and 0.19 [SE=0.02], respectively). TRD was positively associated with the polygenic risk score (PRS) of attention deficit hyperactivity disorder and negatively associated with the PRS of intelligence compared to non-TRD. It was more strongly associated with unfavourable clinical-demographic variables than non-TRD. This study demonstrated that MDD and TRD can be reliably defined using primary care records and provides the first large scale population assessment of the genetic, clinical and demographic characteristics of TRD.Keywords
All Related Versions
- Published version: Molecular Psychiatry, 26 (7), 3363.
This publication has 49 references indexed in Scilit:
- Prevalence and Characteristics of Probable Major Depression and Bipolar Disorder within UK Biobank: Cross-Sectional Study of 172,751 ParticipantsPLOS ONE, 2013
- Characterization of Treatment Resistant Depression Episodes in a Cohort of Patients from a US Commercial Claims DatabasePLOS ONE, 2013
- A Better Coefficient of Determination for Genetic Profile AnalysisGenetic Epidemiology, 2012
- Switching Antidepressant Class Does Not Improve Response or Remission in Treatment-Resistant DepressionJournal of Clinical Psychopharmacology, 2011
- GCTA: A Tool for Genome-wide Complex Trait AnalysisThe American Journal of Human Genetics, 2011
- Validity of diagnostic coding within the General Practice Research Database: a systematic reviewBritish Journal of General Practice, 2010
- What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With DepressionPsychiatric Services, 2009
- Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression.Journal of Consulting and Clinical Psychology, 2009
- Neighborhood Income and Income Distribution and the Use of Cigarettes, Alcohol, and MarijuanaAmerican Journal of Preventive Medicine, 2007
- Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical PracticeAmerican Journal of Psychiatry, 2006